Biogen (BIIB) Construction in Progress (2009 - 2025)

Biogen (BIIB) has reported Construction in Progress for 17 consecutive years, with $163.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Construction in Progress fell 47.11% year-over-year to $163.1 million; the TTM figure through Dec 2025 stood at $163.1 million (down 47.11% YoY), while the FY2025 annual figure was $163.1 million, down 47.11% from the prior year.
• Construction in Progress came in at $163.1 million for Q4 2025 at Biogen, down from $308.4 million in the prior quarter.
• The five-year high for Construction in Progress was $1.9 billion in Q1 2021, with the low at $163.1 million in Q4 2025.
• Average Construction in Progress over 5 years is $754.1 million, with a median of $711.1 million recorded in 2022.
• Across the five-year window, Construction in Progress rose 15.38% in 2022 and plunged 68.38% in 2024, its largest moves.
• Year by year, Construction in Progress stood at $770.3 million in 2021, then climbed by 15.38% to $888.8 million in 2022, then rose by 9.74% to $975.4 million in 2023, then tumbled by 68.38% to $308.4 million in 2024, then slumped by 47.11% to $163.1 million in 2025.
• According to Business Quant data, Construction in Progress over the past three periods registered $163.1 million, $308.4 million, and $975.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.